The submitting company did not present sufficiently robust clinical and economic analyses to gain acceptance says the SMC.
Venetoclax is accepted for restricted use within NHS Scotland in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia.
Avatrombopag is accepted for use within NHS Scotland for severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
Leading Colleges have released advice for healthcare professionals to ensure they provide screening results to pregnant women and their partners in an unbiased and non-directive way, making families aware of their options and giving them time to decide their next steps.
A technical and clinical evaluation has confirmed OptiGene RT-LAMP tests to be accurate and sensitive enough to be used for COVID-19 testing, including for those without symptoms, says DHSC.